(R)-5-Aminopiperidin-2-one hydrochloride

Catalog No. :
ACOWVQ562
CAS No. :
1003021-01-9
Molecular Formula :
C5H11ClN2O
Molecular Weight :
150.61

IUPAC Name:(R)-5-aminopiperidin-2-one hydrochloride

(R)-5-Aminopiperidin-2-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$272.00Login to see priceIn stockInquiry
250mg95%$434.00Login to see priceIn stockInquiry
500mg95%$721.00Login to see priceIn stockInquiry
1g95%$1081.00Login to see priceIn stockInquiry
5g95%$3243.00Login to see priceIn stockInquiry
10g95%$5405.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-5-Aminopiperidin-2-one hydrochloride
IUPAC Name(R)-5-aminopiperidin-2-one hydrochloride
MDL No.MFCD03094720
Molecular FormulaC5H11ClN2O
Molecular Weight150.61
SMILESO=C1NC[C@H](N)CC1.[H]Cl
InChI KeyKFJLLOJCPFYWRV-PGMHMLKASA-N
Synonym1003021-01-9 | (R)-5-Aminopiperidin-2-one hydrochloride | (R)-5-Amino-piperidin-2-one HCl | (5r)-5-aminopiperidin-2-one hydrochloride | (5R)-5-aminopiperidin-2-one;hydrochloride | (R)-5-Aminopiperidin-2-one HCl | MFCD03094720 | 2-Piperidinone, 5-amino-, hydrochloride (
CAS No.1003021-01-9
PubChem CID42614519

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOWVQ562 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUQZ152 route compound structure diagram
    ACEUQZ1521228566-94-6 In Stock
  2. Then
  3. ACOWVQ562 route product structure diagram
    ACOWVQ5621003021-01-9 In Stock
Inquiry

2. ACOWVQ562 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWVQ562 route product structure diagram
    ACOWVQ5621003021-01-9 In Stock
Inquiry

Comments (0)